Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Clavel

Showing results (111-120 of 155) with videos related to

Pageof 16
Sort By:
Therapie|September 1, 1992
[Multicenter prospective study of cardiac accidents during treatments with 5-FU]F Sorbette, I Simon, J Bonneterre, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1993
The use of recombinant human granulocyte-macrophage colony-stimulating factor with combination chemotherapy in the treatment of advanced adult soft-tissue sarcomas: early results from the EORTC Soft-Tissue and Bone Sarcoma GroupW P Steward, J Verweij, R Somers, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 1, 1993
Granulocyte-macrophage colony-stimulating factor allows safe escalation of dose-intensity of chemotherapy in metastatic adult soft tissue sarcomas: a study of the European Organization for Research and Treatment of Cancer Soft Tissue and Bone Sarcoma GroupW P Steward, J Verweij, R Somers, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1995
Phase I study of RP 49532A, a new protein-synthesis inhibitor, in patients with advanced refractory solid tumorsG Catimel, R Coquard, J P Guastalla, et al.
Medical and Pediatric Oncology|January 1, 1994
The role of fast neutron therapy in unresectable pelvic osteosarcoma: preliminary reportC Carrie, N Breteau, S Negrier, et al.
Cancer|October 15, 1984
Combination chemotherapy with cisplatin, methotrexate, bleomycin, and vincristine (CABO) in advanced squamous cell carcinoma of the head and neckM Rozencweig, P Dodion, U Bruntsch, et al.
Journal of Chemotherapy (Florence, Italy)|April 17, 2007
Clinical phase I and pharmacology study of gemcitabine (2', 2'-difluorodeoxycytidine) administered in a two-weekly scheduleG J Peters, M Clavel, P Noordhuis, et al.
British Journal of Cancer|May 1, 1993
Multivariate analysis of prognostic factors in patients with non HIV-related primary cerebral lymphoma. A proposal for a prognostic scoringJ Y Blay, C Lasset, C Carrie, et al.
Bone Marrow Transplantation|November 1, 1992
High dose chemotherapy with ABMT in soft tissue sarcomas: a report of 22 casesC Dumontet, P Biron, E Bouffet, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|July 1, 1994
Docetaxel (Taxotere): an active drug for the treatment of patients with advanced squamous cell carcinoma of the head and neck. EORTC Early Clinical Trials GroupG Catimel, J Verweij, V Mattijssen, et al.
Pageof 16

Showing results (111-120 of 155) with videos related to

Sort By:
Pageof 16
Therapie|September 1, 1992
[Multicenter prospective study of cardiac accidents during treatments with 5-FU]F Sorbette, I Simon, J Bonneterre, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1993
The use of recombinant human granulocyte-macrophage colony-stimulating factor with combination chemotherapy in the treatment of advanced adult soft-tissue sarcomas: early results from the EORTC Soft-Tissue and Bone Sarcoma GroupW P Steward, J Verweij, R Somers, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 1, 1993
Granulocyte-macrophage colony-stimulating factor allows safe escalation of dose-intensity of chemotherapy in metastatic adult soft tissue sarcomas: a study of the European Organization for Research and Treatment of Cancer Soft Tissue and Bone Sarcoma GroupW P Steward, J Verweij, R Somers, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1995
Phase I study of RP 49532A, a new protein-synthesis inhibitor, in patients with advanced refractory solid tumorsG Catimel, R Coquard, J P Guastalla, et al.
Medical and Pediatric Oncology|January 1, 1994
The role of fast neutron therapy in unresectable pelvic osteosarcoma: preliminary reportC Carrie, N Breteau, S Negrier, et al.
Cancer|October 15, 1984
Combination chemotherapy with cisplatin, methotrexate, bleomycin, and vincristine (CABO) in advanced squamous cell carcinoma of the head and neckM Rozencweig, P Dodion, U Bruntsch, et al.
Journal of Chemotherapy (Florence, Italy)|April 17, 2007
Clinical phase I and pharmacology study of gemcitabine (2', 2'-difluorodeoxycytidine) administered in a two-weekly scheduleG J Peters, M Clavel, P Noordhuis, et al.
British Journal of Cancer|May 1, 1993
Multivariate analysis of prognostic factors in patients with non HIV-related primary cerebral lymphoma. A proposal for a prognostic scoringJ Y Blay, C Lasset, C Carrie, et al.
Bone Marrow Transplantation|November 1, 1992
High dose chemotherapy with ABMT in soft tissue sarcomas: a report of 22 casesC Dumontet, P Biron, E Bouffet, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|July 1, 1994
Docetaxel (Taxotere): an active drug for the treatment of patients with advanced squamous cell carcinoma of the head and neck. EORTC Early Clinical Trials GroupG Catimel, J Verweij, V Mattijssen, et al.
Pageof 16